However, even at this early stage, our data are suggestive of the usefulness of LZIC as a biomarker for patient stratification, given that its expression is strongly correlated with survival of patients suffering from clear cell renal carcinoma. The gene discussed is LZIC; the disease is clear cell renal carcinoma.